These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 20417001)

  • 1. Emerging role of the bufadienolides in cardiovascular and kidney diseases.
    Puschett JB; Agunanne E; Uddin MN
    Am J Kidney Dis; 2010 Aug; 56(2):359-70. PubMed ID: 20417001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analytical aspects of marinobufagenin.
    Lenaerts C; Demeyer M; Gerbaux P; Blankert B
    Clin Chim Acta; 2013 Jun; 421():193-201. PubMed ID: 23470428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marinobufagenin, resibufogenin and preeclampsia.
    Puschett JB; Agunanne E; Uddin MN
    Biochim Biophys Acta; 2010 Dec; 1802(12):1246-53. PubMed ID: 20167272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous cardiac glycosides: hormones using the sodium pump as signal transducer.
    Schoner W; Scheiner-Bobis G
    Semin Nephrol; 2005 Sep; 25(5):343-51. PubMed ID: 16139690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous cardiotonic steroids.
    Schoner W
    Cell Mol Biol (Noisy-le-grand); 2001 Mar; 47(2):273-80. PubMed ID: 11355001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of endogenous cardiotonic steroids in pathogenesis of cardiovascular and renal complications of arterial hypertension.
    Paczula A; Więcek A; Piecha G
    Postepy Hig Med Dosw (Online); 2016 Mar; 70():243-50. PubMed ID: 27117099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular effects of the bufodienolides.
    Puschett JB
    Trans Am Clin Climatol Assoc; 2008; 119():103-12; discussion 112. PubMed ID: 18596850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marinobufagenin levels in preeclamptic patients: a preliminary report.
    Agunanne E; Horvat D; Harrison R; Uddin MN; Jones R; Kuehl TJ; Ghanem DA; Berghman LR; Lai X; Li J; Romo D; Puschett JB
    Am J Perinatol; 2011 Aug; 28(7):509-14. PubMed ID: 21380994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of endogenous cardiotonic steroids in sodium homeostasis.
    Schoner W; Scheiner-Bobis G
    Nephrol Dial Transplant; 2008 Sep; 23(9):2723-9. PubMed ID: 18556748
    [No Abstract]   [Full Text] [Related]  

  • 10. Marinobufagenin predicts and resibufogenin prevents preeclampsia: a review of the evidence.
    Puschett JB
    Am J Perinatol; 2012 Nov; 29(10):777-85. PubMed ID: 22814872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potassium, Na+-K+ pump inhibitor and low-renin hypertension.
    Haddy FJ
    Clin Invest Med; 1987 Nov; 10(6):547-54. PubMed ID: 2831002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resibufogenin corrects hypertension in a rat model of human preeclampsia.
    Vu H; Ianosi-Irimie M; Danchuk S; Rabon E; Nogawa T; Kamano Y; Pettit GR; Wiese T; Puschett JB
    Exp Biol Med (Maywood); 2006 Feb; 231(2):215-20. PubMed ID: 16446498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resibufogenin prevents the manifestations of preeclampsia in an animal model of the syndrome.
    Horvat D; Severson J; Uddin MN; Mitchell B; Puschett JB
    Hypertens Pregnancy; 2010 Jan; 29(1):1-9. PubMed ID: 19277924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous marinobufagenin-like immunoreactive substance. A possible endogenous Na, K-ATPase inhibitor with vasoconstrictor activity.
    Bagrov AY; Dmitrieva RI; Fedorova OV; Kazakov GP; Roukoyatkina NI; Shpen VM
    Am J Hypertens; 1996 Oct; 9(10 Pt 1):982-90. PubMed ID: 8896650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Na/K-ATPase endocytosis couples pumping and leaking activities in renal epithelial cells: a hypothesis.
    Liu J
    Cell Mol Biol (Noisy-le-grand); 2006 Dec; 52(8):97-104. PubMed ID: 17535743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma marinobufagenin-like and ouabain-like immunoreactivity during saline volume expansion in anesthetized dogs.
    Bagrov AY; Fedorova OV; Dmitrieva RI; French AW; Anderson DE
    Cardiovasc Res; 1996 Feb; 31(2):296-305. PubMed ID: 8730407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of cardiotonic steroids in the pathogenesis of cardiomyopathy in chronic kidney disease.
    Pavlovic D
    Nephron Clin Pract; 2014; 128(1-2):11-21. PubMed ID: 25341357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marinobufagenin extraction from Rhinella marina toad glands: Alternative approaches for a systematized strategy.
    Lenaerts C; Wells M; Hambÿe S; Blankert B
    J Sep Sci; 2019 Apr; 42(7):1384-1392. PubMed ID: 30667156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ["Goldblatt phenomenon of the uterus" and latent kidney disease as the cause of pregnancy-induced hypertension--epidemiology and therapeutic consequences].
    Künzel W
    Geburtshilfe Frauenheilkd; 1990 Nov; 50(11):833-41. PubMed ID: 2283006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of resibufogenin in experimental hypertension.
    Danchuk S; Sukhanov S; Horvat D; Uddin MN; Puschett JB
    Am J Nephrol; 2008; 28(1):8-13. PubMed ID: 17890853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.